ArticleJournal of family medicine and primary care2025

Continuous glucose monitoring guides glucagon-like peptide 1-based therapy use and optimization in people with type 2 diabetes.

Rita Parsiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.